These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32568866)

  • 1. Regression of liver fibrosis: evidence and challenges.
    Sun YM; Chen SY; You H
    Chin Med J (Engl); 2020 Jul; 133(14):1696-1702. PubMed ID: 32568866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving strategies for liver fibrosis staging: Non-invasive assessment.
    Stasi C; Milani S
    World J Gastroenterol; 2017 Jan; 23(2):191-196. PubMed ID: 28127192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Qualitative pathological assessment of liver fibrosis regression after antiviral therapy in patients with chronic hepatitis B].
    Sun YM; Zhou JL; Wang L; Wu XN; Chen YP; Piao HX; Lu LG; Jiang W; Xu YQ; Feng B; Nan YM; Xie W; Chen GF; Zheng HW; Li H; Ding HG; Liu H; Lyu FD; Shao C; Wang TL; Ou XJ; Wang BQ; Chen SY; You H; Jia JD
    Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):819-826. PubMed ID: 29325275
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-invasive diagnosis of advanced fibrosis and cirrhosis.
    Sharma S; Khalili K; Nguyen GC
    World J Gastroenterol; 2014 Dec; 20(45):16820-30. PubMed ID: 25492996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort.
    Munsterman ID; Duijnhouwer AL; Kendall TJ; Bronkhorst CM; Ronot M; van Wettere M; van Dijk APJ; Drenth JPH; Tjwa ETTL;
    Eur Heart J; 2019 Apr; 40(13):1057-1068. PubMed ID: 30346512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The non-invasive assessment of hepatic fibrosis.
    Gheorghe G; Bungău S; Ceobanu G; Ilie M; Bacalbaşa N; Bratu OG; Vesa CM; Găman MA; Diaconu CC
    J Formos Med Assoc; 2021 Feb; 120(2):794-803. PubMed ID: 32861550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of transient elastography (Fibroscan®) in the assessment of fibrosis in patients with chronic liver disease].
    Alvarez D; Anders M; Mella J; Amante M; Orozco F; Mastai R
    Medicina (B Aires); 2012; 72(1):10-4. PubMed ID: 22257449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal monitoring of liver fibrosis status by transient elastography in chronic hepatitis B patients during long-term entecavir treatment.
    Wu SD; Liu LL; Cheng JL; Liu Y; Cheng LS; Wang SQ; Ma W; Chen LP; Tseng YJ; Wang JY; Shen XZ; Jiang W
    Clin Exp Med; 2018 Aug; 18(3):433-443. PubMed ID: 29696462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease.
    Castera L
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):291-303. PubMed ID: 21497746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy?
    Castera L; Bedossa P
    Liver Int; 2011 Jan; 31 Suppl 1():13-7. PubMed ID: 21205132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Present situation on non-invasive assessment of liver fibrosis/cirrhosis].
    Zhang QD; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2018 May; 26(5):325-327. PubMed ID: 29996197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-invasive assessment of liver fibrosis].
    Cohen-Ezra O; Ben-Ari Z
    Harefuah; 2015 Mar; 154(3):204-7, 210, 209. PubMed ID: 25962254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-invasive diagnostic methods of fibrosis in chronic hepatitis C virus infection: their role in treatment indication, follow-up and assessment of prognosis].
    Pár A; Vincze Á; Pár G
    Orv Hetil; 2015 May; 156(21):855-61. PubMed ID: 26038993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive tools to assess hepatic fibrosis: ready for prime time?
    Schmeltzer PA; Talwalkar JA
    Gastroenterol Clin North Am; 2011 Sep; 40(3):507-21. PubMed ID: 21893271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive assessment of liver fibrosis and prognosis.
    Hagan M; Asrani SK; Talwalkar J
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1251-60. PubMed ID: 26377444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive Assessment of Liver Fibrosis.
    Castera L
    Dig Dis; 2015; 33(4):498-503. PubMed ID: 26159265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.
    Kim JH; Kim MN; Han KH; Kim SU
    Liver Int; 2015 Apr; 35(4):1103-15. PubMed ID: 24976523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness.
    Stasi C; Milani S
    World J Gastroenterol; 2016 Jan; 22(4):1711-20. PubMed ID: 26819535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing liver fibrosis.
    Castera L
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):541-52. PubMed ID: 19072402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.